Children's Oncology Group's 2023 blueprint for research: Radiation oncology

John A. Kalapurakal; Suzanne L. Wolden; Daphne Haas-Kogan; Nadia N. Laack; Chia ho Hua; Arnold C. Paulino; Christine E. Hill-Kayser; Bradford S. Hoppe; Thomas J. Fitzgerald

doi:10.1002/pbc.30593

Children's Oncology Group's 2023 blueprint for research: Radiation oncology

John A. Kalapurakal, Suzanne L. Wolden, Daphne Haas-Kogan, Nadia N. Laack, Chia ho Hua, Arnold C. Paulino, Christine E. Hill-Kayser, Bradford S. Hoppe, Thomas J. Fitzgerald

Radiation Oncology

Research output: Contribution to journal › Article › peer-review

Abstract

Radiation oncology is an integral part of the multidisciplinary team caring for children with cancer. The primary goal of our committee is to enable the delivery of the safest dose of radiation therapy (RT) with the maximal potential for cure, and to minimize toxicity in children by delivering lower doses to normal tissues using advanced technologies like intensity-modulated RT (IMRT) and proton therapy. We provide mentorship for y ators and are actively involved in educating the global radiation oncology community. We are leaders in the effort to discover novel radiosensitizers, radioprotectors, and advanced RT technologies that could help improve outcomes of children with cancer.

Original language	English (US)
Article number	e30593
Journal	Pediatric Blood and Cancer
Volume	70
Issue number	S6
DOIs	https://doi.org/10.1002/pbc.30593
State	Published - Sep 2023

Keywords

chemotherapy
late effects of cancer treatment
long-term survival
molecular biology
radiation therapy

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.30593

Cite this

@article{74e2faa132d443dbb6d11ca4203aade1,

title = "Children's Oncology Group's 2023 blueprint for research: Radiation oncology",

abstract = "Radiation oncology is an integral part of the multidisciplinary team caring for children with cancer. The primary goal of our committee is to enable the delivery of the safest dose of radiation therapy (RT) with the maximal potential for cure, and to minimize toxicity in children by delivering lower doses to normal tissues using advanced technologies like intensity-modulated RT (IMRT) and proton therapy. We provide mentorship for y ators and are actively involved in educating the global radiation oncology community. We are leaders in the effort to discover novel radiosensitizers, radioprotectors, and advanced RT technologies that could help improve outcomes of children with cancer.",

keywords = "chemotherapy, late effects of cancer treatment, long-term survival, molecular biology, radiation therapy",

author = "Kalapurakal, {John A.} and Wolden, {Suzanne L.} and Daphne Haas-Kogan and Laack, {Nadia N.} and Hua, {Chia ho} and Paulino, {Arnold C.} and Hill-Kayser, {Christine E.} and Hoppe, {Bradford S.} and Fitzgerald, {Thomas J.}",

note = "Publisher Copyright: {\textcopyright} 2023 Wiley Periodicals LLC.",

year = "2023",

month = sep,

doi = "10.1002/pbc.30593",

language = "English (US)",

volume = "70",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "S6",

}

TY - JOUR

T1 - Children's Oncology Group's 2023 blueprint for research

T2 - Radiation oncology

AU - Kalapurakal, John A.

AU - Wolden, Suzanne L.

AU - Haas-Kogan, Daphne

AU - Laack, Nadia N.

AU - Hua, Chia ho

AU - Paulino, Arnold C.

AU - Hill-Kayser, Christine E.

AU - Hoppe, Bradford S.

AU - Fitzgerald, Thomas J.

PY - 2023/9

Y1 - 2023/9

N2 - Radiation oncology is an integral part of the multidisciplinary team caring for children with cancer. The primary goal of our committee is to enable the delivery of the safest dose of radiation therapy (RT) with the maximal potential for cure, and to minimize toxicity in children by delivering lower doses to normal tissues using advanced technologies like intensity-modulated RT (IMRT) and proton therapy. We provide mentorship for y ators and are actively involved in educating the global radiation oncology community. We are leaders in the effort to discover novel radiosensitizers, radioprotectors, and advanced RT technologies that could help improve outcomes of children with cancer.

AB - Radiation oncology is an integral part of the multidisciplinary team caring for children with cancer. The primary goal of our committee is to enable the delivery of the safest dose of radiation therapy (RT) with the maximal potential for cure, and to minimize toxicity in children by delivering lower doses to normal tissues using advanced technologies like intensity-modulated RT (IMRT) and proton therapy. We provide mentorship for y ators and are actively involved in educating the global radiation oncology community. We are leaders in the effort to discover novel radiosensitizers, radioprotectors, and advanced RT technologies that could help improve outcomes of children with cancer.

KW - chemotherapy

KW - late effects of cancer treatment

KW - long-term survival

KW - molecular biology

KW - radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=85165570391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85165570391&partnerID=8YFLogxK

U2 - 10.1002/pbc.30593

DO - 10.1002/pbc.30593

M3 - Article

C2 - 37486145

AN - SCOPUS:85165570391

SN - 1545-5009

VL - 70

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - S6

M1 - e30593

ER -

Children's Oncology Group's 2023 blueprint for research: Radiation oncology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this